Clindamycin versus chloramphenicol in treatment of anaerobic infections: a prospective, randomized, double-blind study.
Seventy patients with substantiated anaerobic infections were treated parenterally with clindamycin or chloramphenicol in a prospective, double-blind, randomized study. No significant differences in clinical response or toxicity were noted between the two groups of patients.
D001421:Bacteria, Anaerobic / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002701:Chloramphenicol / Q000009:adverse effects / Q000627:therapeutic use*; D002981:Clindamycin / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D011446:Prospective Studies; D011897:Random Allocation
D002981:Clindamycin; D002701:Chloramphenicol